000 | 01774 a2200505 4500 | ||
---|---|---|---|
005 | 20250515233424.0 | ||
264 | 0 | _c20110418 | |
008 | 201104s 0 0 eng d | ||
022 | _a1557-8127 | ||
024 | 7 |
_a10.1089/adt.2009.0260 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aScholz, Anne-Kathrin | |
245 | 0 | 0 |
_aA flexible multiwell format for immunofluorescence screening microscopy of small-molecule inhibitors. _h[electronic resource] |
260 |
_bAssay and drug development technologies _cOct 2010 |
||
300 |
_a571-80 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 | _aCOS Cells |
650 | 0 | 4 | _aCaco-2 Cells |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 |
_aCentrosome _xdrug effects |
650 | 0 | 4 | _aChlorocebus aethiops |
650 | 0 | 4 | _aDimethylpolysiloxanes |
650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
650 | 0 | 4 | _aHigh-Throughput Screening Assays |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterphase _xdrug effects |
650 | 0 | 4 | _aMicroscopy, Fluorescence |
650 | 0 | 4 | _aMitotic Index |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aRNA, Small Interfering _xgenetics |
650 | 0 | 4 | _aSmall Molecule Libraries |
650 | 0 | 4 | _aTissue Array Analysis |
650 | 0 | 4 | _aTransfection |
700 | 1 | _aKlebl, Bert M | |
700 | 1 | _aMorkel, Markus | |
700 | 1 | _aLehrach, Hans | |
700 | 1 | _aDahl, Andreas | |
700 | 1 | _aLange, Bodo M H | |
773 | 0 |
_tAssay and drug development technologies _gvol. 8 _gno. 5 _gp. 571-80 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1089/adt.2009.0260 _zAvailable from publisher's website |
999 |
_c20006506 _d20006506 |